Dermatology - Modern Medicine

ADVERTISEMENT

TOP STORY
Safety check: FDA reviews Botox, Myobloc
Washington—The Food and Drug Administration's decision to review the safety of botulinum-toxin drugs Botox, Botox Cosmetic and Myobloc has generated reactions ranging from surprise to cynicism in the dermatologic community

ADVERTISEMENT

ADVERTISEMENT

SUMMARY: Clinical articles and industry reports on the diagnosis and treatment of benign and malignant dermatologic disorders. Topics cover skin tumors, allergic and non-allergic skin disorders and the recognition of skin manifestations of systemic and infectious diseases.

Click here